1 Product identity
Ingredient risk
Contains a high-risk ingredient

Melatonin 5 mg

BrandSeeking HealthNon-Nutrient/Non-Botanical Lozenge 5 ingredients 1 high-risk 1 caution DSLD #174529
Net contents: 90 Lozenge(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-03-23
2 Ingredients (5)
IngredientGroupSafety
MelatoninMelatoninUse with Caution
XylitolXylitolHigh risk
Ascorbyl PalmitateVitamin CGenerally Safe
natural Cherry flavorcherry (unspecified)
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Xylitol — Dog owner not warned about xylitol toxicity — potentially fatal to dogs [1]
⚠️ Use with caution — restricted in some markets
Melatonin  🇯🇵 🇪🇺 🇦🇺 🇩🇪 🇬🇧 — Not approved as food supplement. Classified as pharmaceutical.
3 Safety cross-reference
Melatonin — Use with Caution
⚠ Daytime drowsiness
⚠ May worsen depression
Xylitol — High risk
⚠ GI distress (gas, bloating, diarrhea) dose-dependent
⚠ Cardiovascular risk: 2023 Cleveland Clinic study linked xylitol to increased thrombotic events
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID174529
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-03-23
6 More from Seeking Health
View Seeking Health Safety Scorecard → 53 products
5-HTP 50 mg5-HTP Extended Release 200 mgBenfotiamineBone NutrientsCaprylic Acid 250 mgCopper 2 mg
7 Cite this page
Vancouver
Pkhakadze G. Melatonin 5 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 28]. Available from: https://supplement.ge/products/melatonin-5-mg-174529/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG